Fundz

Can Fite Bio Pharma Ltd. reported raising $2.4 Million in an initial SEC Form D filing, from an offering of $2.4 Million

PUBLIC · CANFJan 24, 2020

Amount Raised

$2.4 Million

$2.4 Million sold, per SEC Form D (first sale Jan 24, 2020)

Round Type

Seed

IsraelHealthcare

Quick answer

Can-Fite BioPharma Ltd. raised $2.4 Million in a Seed round, dated January 24, 2020. Can-Fite BioPharma Ltd. is based in Israel.

How much did Can-Fite BioPharma Ltd. raise?
Can-Fite BioPharma Ltd. raised $2.4 Million in a Seed round on January 24, 2020.
What does Can-Fite BioPharma Ltd. do?
Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and
Where is Can-Fite BioPharma Ltd. based and how big is it?
Can-Fite BioPharma Ltd. is based in Israel.
Who are the decision-makers at Can-Fite BioPharma Ltd?
Fundz holds 1 contact at Can-Fite BioPharma Ltd., including the Vice President of Business Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Can-Fite BioPharma Ltd. that raised within 45 days of this round, from Fundz verified event records.

  • Soterius, Inc. raised $1.5M (Seed) on March 9, 2020.
  • CollPlant Biotechnologies Ltd raised $4.5M (Seed) on March 9, 2020.
  • OnKure Therapeutics raised $1M (Seed) on March 6, 2020.
  • Verastem Oncology raised $100M on March 6, 2020.
  • Adamis Pharmaceuticals Corp raised $6.1M on March 6, 2020.
  • Kinnos raised $6.3M on March 5, 2020.

Who to call at Can-Fite BioPharma Ltd., and when

A new round usually means Can-Fite BioPharma Ltd. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Can-Fite BioPharma Ltd. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Can-Fite BioPharma Ltd., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Can-Fite BioPharma Ltd.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Can-Fite BioPharma Ltd.

Location

Israel

About

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Can-Fite BioPharma Ltd. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSari F., Vice President of Business DevelopmentSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Can-Fite BioPharma Ltd.'s next move

See what Strategic adds

Can-Fite BioPharma Ltd. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.